Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
2 hedge funds and large institutions have $8K invested in Adial Pharmaceuticals Warrant in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
20% less capital invested
Capital invested by funds: $10K → $8K (-$2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.15K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Ameriprise
Minneapolis,
Minnesota
| $7K | – | – | – |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $1K | +$2.15K | +3,255 | New |
|
ADILW Hedge Fund Activity: Q1 2022 in Review
2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q1 2022, worth a combined $8K — down 20% from $10K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ADILW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $2.15K.
- 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q1 2022, up from 1 in Q4 2021.
- Funds reported $8K of Adial Pharmaceuticals Warrant stock for Q1 2022, down 20% quarter-over-quarter.
- 1 fund opened new Adial Pharmaceuticals Warrant positions in Q1 2022 and 0 closed out, a net change of +1 holder.
- The largest Adial Pharmaceuticals Warrant buyer in Q1 2022 was Wolverine Asset Management, an estimated $2.15K added.
Based on aggregated 13F filings for Q1 2022.